论文部分内容阅读
Objective Burkitt lymphoma(BL)is a highly aggressive but potentially curable type of B-cell non-Hodgkin lymphoma(NHL)with a cellular doubling time of 24–48 hours.Derived from B-cell germinal centers,BL was first described as a distinct clinical entity in 1958.